The White House has blamed the Biden administration for failing to advance domestic production or fill the reserve.

19-year-old Adam Kovalčík has created a stronger—and much cheaper—version of a powerful emerging medication known as ...

For the first time, many people in the United States who want to protect themselves against the flu this respiratory virus ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

Invivyd Aligns with U.S. FDA on Rapid Pathway to Full Approval (BLA) of Vaccine Alternative Monoclonal Antibody VYD2311 to Protect American Adults and Adolescents from COVID-19 ...

With the latest COVID-19 surge, information on testing and vaccinations for those who are uninsured is becoming hard to find.

Robert F. Kennedy Jr. delivered a win to his anti-vaccine supporters on Thursday by reviving a task force meant to scrutinize ...

“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.

The Food and Drug Administration is considering pulling its authorization of Pfizer’s COVID-19 vaccine for healthy children ...

Diagnostics' progress on their PCR platform, with key trials in 2025 and commercialization plans by 2026, targeting U.S. and global markets.

Key Points GAAP revenue jumped 413% year over year to $11.8 million in Q2 2025, but fell far short of analyst estimates, with GAAP revenue of $11.8 million missing the consensus of $23.2 million by 49 ...

Invivyd ( ($IVVD) ) just unveiled an update. On August 14, 2025, Invivyd announced its alignment with the U.S. FDA on a rapid pathway to full ...